A team led by researchers at the University of Southern California and University of Miami has developed a nine-protein panel for predicting the progression of bladder cancer.

In a recently published study of primary tumors from 212 bladder cancer patients, the panel, combined with patient smoking history, improved predictions of survival compared to standard clinicopathological data alone.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.